Annual Retained Earnings
-$30.78 M
-$5.00 M-19.40%
December 31, 2023
Summary
- As of February 26, 2025, PTIX annual retained earnings is -$30.78 million, with the most recent change of -$5.00 million (-19.40%) on December 31, 2023.
- During the last 3 years, PTIX annual retained earnings has fallen by -$13.08 million (-73.90%).
- PTIX annual retained earnings is now -2987.23% below its all-time high of $1.07 million, reached on December 31, 2006.
Performance
PTIX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$34.75 M
-$640.80 K-1.88%
September 30, 2024
Summary
- As of February 26, 2025, PTIX quarterly retained earnings is -$34.75 million, with the most recent change of -$640.80 thousand (-1.88%) on September 30, 2024.
- Over the past year, PTIX quarterly retained earnings has dropped by -$640.80 thousand (-1.88%).
- PTIX quarterly retained earnings is now -5107.13% below its all-time high of $694.00 thousand, reached on March 31, 2007.
Performance
PTIX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PTIX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.4% | -1.9% |
| 3 y3 years | -73.9% | -1.9% |
| 5 y5 years | -129.7% | -1.9% |
PTIX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.5% | at low | -56.4% | at low |
| 5 y | 5-year | -103.2% | at low | -129.4% | at low |
| alltime | all time | -2987.2% | +84.3% | -5107.1% | +80.9% |
Protagenic Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$34.75 M(+1.9%) |
| Jun 2024 | - | -$34.11 M(+4.9%) |
| Mar 2024 | - | -$32.50 M(+5.6%) |
| Dec 2023 | -$30.78 M(+19.4%) | -$30.78 M(+5.8%) |
| Sep 2023 | - | -$29.10 M(+5.0%) |
| Jun 2023 | - | -$27.71 M(+4.6%) |
| Mar 2023 | - | -$26.50 M(+2.8%) |
| Dec 2022 | -$25.78 M(+16.0%) | -$25.78 M(+2.4%) |
| Sep 2022 | - | -$25.18 M(+3.8%) |
| Jun 2022 | - | -$24.25 M(+2.8%) |
| Mar 2022 | - | -$23.58 M(+6.1%) |
| Dec 2021 | -$22.22 M(+25.6%) | -$22.22 M(+4.2%) |
| Sep 2021 | - | -$21.33 M(+4.3%) |
| Jun 2021 | - | -$20.45 M(+8.2%) |
| Mar 2021 | - | -$18.91 M(+6.8%) |
| Dec 2020 | -$17.70 M(+16.8%) | -$17.70 M(+3.0%) |
| Sep 2020 | - | -$17.18 M(+5.9%) |
| Jun 2020 | - | -$16.22 M(+3.6%) |
| Mar 2020 | - | -$15.65 M(+3.3%) |
| Dec 2019 | -$15.15 M(+13.1%) | -$15.15 M(+5.2%) |
| Sep 2019 | - | -$14.40 M(+0.9%) |
| Jun 2019 | - | -$14.28 M(+2.0%) |
| Mar 2019 | - | -$14.00 M(+4.5%) |
| Dec 2018 | -$13.40 M(+23.6%) | -$13.40 M(+6.3%) |
| Sep 2018 | - | -$12.61 M(+4.1%) |
| Jun 2018 | - | -$12.11 M(+5.9%) |
| Mar 2018 | - | -$11.44 M(+5.5%) |
| Dec 2017 | -$10.84 M(+26.3%) | -$10.84 M(+6.9%) |
| Sep 2017 | - | -$10.15 M(+4.7%) |
| Jun 2017 | - | -$9.69 M(+4.9%) |
| Mar 2017 | - | -$9.24 M(+7.7%) |
| Dec 2016 | -$8.58 M(+451.9%) | -$8.58 M(+6.9%) |
| Sep 2016 | - | -$8.03 M(+6.0%) |
| Jun 2016 | - | -$7.57 M(+7.4%) |
| Mar 2016 | - | -$7.05 M(+282.1%) |
| Dec 2015 | - | -$1.84 M(+9.4%) |
| Sep 2015 | - | -$1.69 M(+8.4%) |
| Jun 2015 | -$1.55 M(+44.1%) | -$1.55 M(+7.8%) |
| Mar 2015 | - | -$1.44 M(+9.0%) |
| Dec 2014 | - | -$1.32 M(+11.2%) |
| Sep 2014 | - | -$1.19 M(+10.4%) |
| Jun 2014 | -$1.08 M(-99.4%) | -$1.08 M(-99.4%) |
| Jun 2013 | -$195.53 M(+16.4%) | - |
| Sep 2011 | - | -$182.23 M(+2.5%) |
| Jun 2011 | - | -$177.71 M(+3.6%) |
| Mar 2011 | - | -$171.56 M(+2.1%) |
| Dec 2010 | -$168.05 M | -$168.05 M(+5.1%) |
| Sep 2010 | - | -$159.88 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | -$156.25 M(+3.0%) |
| Mar 2010 | - | -$151.75 M(+2.3%) |
| Dec 2009 | -$148.32 M(+24.8%) | -$148.32 M(+19.3%) |
| Sep 2009 | - | -$124.37 M(+2.0%) |
| Jun 2009 | - | -$121.98 M(+1.6%) |
| Mar 2009 | - | -$120.04 M(+1.0%) |
| Dec 2008 | -$118.85 M(+3755.0%) | -$118.85 M(+5089.9%) |
| Sep 2008 | - | -$2.29 M(+0.2%) |
| Jun 2008 | - | -$2.29 M(-31.8%) |
| Mar 2008 | - | -$3.35 M(+8.7%) |
| Dec 2007 | -$3.08 M(-389.2%) | -$3.08 M(+43.9%) |
| Sep 2007 | - | -$2.14 M(+1009.8%) |
| Jun 2007 | - | -$193.00 K(-127.8%) |
| Mar 2007 | - | $694.00 K(-430.9%) |
| Dec 2006 | $1.07 M(-719.8%) | - |
| Oct 2006 | - | -$209.70 K(+21.9%) |
| Jul 2006 | - | -$172.00 K(+5.7%) |
| Jul 2006 | -$172.00 K(+82.0%) | - |
| Apr 2006 | - | -$162.80 K(+5.7%) |
| Jan 2006 | - | -$154.00 K(+8.5%) |
| Oct 2005 | - | -$141.90 K(-98.1%) |
| Jul 2005 | -$94.50 K(-99.3%) | - |
| Jul 2004 | -$13.90 M(+269.1%) | - |
| Apr 2003 | - | -$7.45 M(+3.3%) |
| Jan 2003 | - | -$7.21 M(+69.9%) |
| Oct 2002 | - | -$4.24 M(+12.6%) |
| Jul 2002 | -$3.77 M(+24.0%) | -$3.77 M(+13.5%) |
| Apr 2002 | - | -$3.32 M(+5.5%) |
| Jan 2002 | - | -$3.15 M(+8.9%) |
| Oct 2001 | - | -$2.89 M(-4.9%) |
| Jul 2001 | -$3.04 M(-4.5%) | -$3.04 M(+11.5%) |
| Apr 2001 | - | -$2.72 M(-0.8%) |
| Jan 2001 | - | -$2.75 M(-3.8%) |
| Oct 2000 | - | -$2.85 M(-10.4%) |
| Jul 2000 | -$3.18 M(-26.3%) | -$3.18 M(-8.2%) |
| Apr 2000 | - | -$3.47 M(-5.8%) |
| Jan 2000 | - | -$3.68 M(-3.2%) |
| Oct 1999 | - | -$3.80 M(-12.0%) |
| Jul 1999 | -$4.32 M(+18.5%) | -$4.32 M(+23.4%) |
| Apr 1999 | - | -$3.50 M(+6.1%) |
| Jan 1999 | - | -$3.30 M(0.0%) |
| Oct 1998 | - | -$3.30 M(-9.4%) |
| Jul 1998 | -$3.64 M(-15.3%) | -$3.64 M(-1.5%) |
| Apr 1998 | - | -$3.70 M(-7.5%) |
| Jan 1998 | - | -$4.00 M(0.0%) |
| Oct 1997 | - | -$4.00 M(-7.0%) |
| Jul 1997 | -$4.30 M | -$4.30 M(+4.9%) |
| Apr 1997 | - | -$4.10 M(0.0%) |
| Jan 1997 | - | -$4.10 M |
FAQ
- What is Protagenic Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual retained earnings year-on-year change?
- What is Protagenic Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly retained earnings year-on-year change?
What is Protagenic Therapeutics annual retained earnings?
The current annual retained earnings of PTIX is -$30.78 M
What is the all time high annual retained earnings for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual retained earnings is $1.07 M
What is Protagenic Therapeutics annual retained earnings year-on-year change?
Over the past year, PTIX annual retained earnings has changed by -$5.00 M (-19.40%)
What is Protagenic Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PTIX is -$34.75 M
What is the all time high quarterly retained earnings for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly retained earnings is $694.00 K
What is Protagenic Therapeutics quarterly retained earnings year-on-year change?
Over the past year, PTIX quarterly retained earnings has changed by -$640.80 K (-1.88%)